COURTNEY HAFNER: Open Payments
NPI 1356827513 · GLENS FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,581 in 102 payments from 13 companies in 2025. Trend: 2023 $896 · 2024 $1,077 · 2025 $1,581
Food & beverage: $1,496Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 28 | $278 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $222 |
| Otsuka America Pharmaceutical, Inc. | 18 | $203 |
| E.R. Squibb & Sons, L.L.C. | 14 | $164 |
| Teva Pharmaceuticals USA, Inc. | 6 | $160 |
| Alkermes, Inc. | 8 | $150 |
| Neurocrine BioSciences, Inc. | 5 | $94 |
| Vanda Pharmaceuticals Inc. | 3 | $93 |
| Supernus Pharmaceuticals, Inc. | 4 | $81 |
| Indivior Inc. | 3 | $53 |
Products named: CAPLYTA, COBENFY, SPRAVATO, REXULTI, INVEGA SUSTENNA, ARISTADA, INGREZZA, FANAPT.
Industry payments across NY — which companies pay providers there.
